Prostate Cancer - Results from #25640

Treatment of low-risk prostate cancer with radical hypofractionated accelerated radiotherapy with cytoprotection (HypoARC): An interim analysis of toxicity and efficacy - Abstract June 16, 2011

Tumor markers in prostate cancer I: Blood-based markers - Abstract June 16, 2011

State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer - Abstract June 16, 2011

Benzyldihydroxyoctenone, a novel nonsteroidal antiandrogen, shows differential apoptotic induction in prostate cancer cells in response to their androgen responsiveness - Abstract June 16, 2011

A miRNA expression signature that separates between normal and malignant prostate tissues - Abstract June 16, 2011

Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer - Abstract June 16, 2011

Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: Technique and outcomes - Abstract June 16, 2011

Diagnosis and treatment of prostate cancer in renal-transplant recipients - Abstract June 15, 2011

Early detection of prostate cancer with emphasis on genetic markers - Abstract June 15, 2011

Role of histopathology and molecular markers in the active surveillance of prostate cancer - Abstract June 15, 2011

Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy - Abstract June 15, 2011

Study of the distribution of microvessels in normal and pathologic prostate using an information-based similarity analysis - Abstract June 15, 2011

Dynamic prediction of metastases after radical prostatectomy for prostate cancer - Abstract June 15, 2011

Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: Results from a prospective phase II randomized trial - Abstract June 15, 2011

Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison - Abstract June 15, 2011

Impact of common medications on serum total prostate-specific antigen levels and risk group assignment in patients with prostate cancer - Abstract June 15, 2011

Editor's Commentary - Prospective evaluation of (11)C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases June 15, 2011

Screening for prostate cancer---the controversy continues, but can it be resolved? - Abstract June 14, 2011

Pathology in prostate research: Optimizing tissue quality - Abstract June 14, 2011

New therapeutic strategies for castration-resistant prostate cancer - Abstract June 14, 2011

Page 1283 of 1333